Gilbert Ray Cisneros, Jr. sold Crinetics Pharmaceuticals Inc (NASDAQ: CRNX)
Gilbert Ray Cisneros, Jr. sold CRNX · disclosed September 4, 2026
Gilbert Ray Cisneros, Jr., a CA House member representing District 31, sold $15,001 - $50,000 of Crinetics Pharmaceuticals Inc (CRNX) on July 30, 2026. Filings associated with Gilbert Ray Cisneros, Jr. disclosed 1 other CRNX transaction (1 purchase) in the 12 months before this trade. Shares of CRNX have risen 115.7% since the first observed purchase on January 29, 2025. The filing was publicly disclosed on September 4, 2026; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Gilbert Ray Cisneros, Jr.'s complete filing history, visit Gilbert Ray Cisneros, Jr.'s full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on CRNX break down as 0 strong buy, 7 buy, 8 hold, 0 sell, 0 strong sell.
- Gilbert Ray Cisneros, Jr. sold CRNX in the amount range of $15,001 - $50,000 on July 30, 2026, filed under the STOCK Act.
- The filing lists Self as the transaction owner and was disclosed 36 days after the trade.
- The asset description in the filing reads 'Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) [ST].'
- Filings associated with Gilbert Ray Cisneros, Jr. disclosed 1 other CRNX transaction (1 purchase) in the 12 months before this trade.
- Shares of CRNX have risen 115.7% since the first observed purchase on January 29, 2025.
- CRNX carried a Q Score of 0 in its equity peer group as of date unavailable.
- CRNX carried a Squeeze Score of 26 as of September 8, 2026.
Did Gilbert Ray Cisneros, Jr. buy or sell CRNX?
The Periodic Transaction Report covers a single sale involving CRNX on July 30, 2026. The filed amount range is $15,001 - $50,000. The asset description reads 'Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) [ST]', as submitted by the filer. The report was submitted on September 4, 2026. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. (House) | Sell | CRNX | $15,001 - $50,000 | July 30, 2026 | September 4, 2026 |
What other CRNX trades has Gilbert Ray Cisneros, Jr. disclosed in the past 12 months?
Filings associated with Gilbert Ray Cisneros, Jr. disclosed 1 other CRNX transaction (1 purchase) in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| March 3, 2026 | Buy | Self | $1,001 - $15,000 | Filing unavailable |
What does the filing show, and what does it not show?
The filing reports a sale involving CRNX by Gilbert Ray Cisneros, Jr. in the amount range of $15,001 - $50,000, with Self listed as the owner. It does not establish Gilbert Ray Cisneros, Jr.'s total holdings in CRNX, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) [ST]', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Gilbert Ray Cisneros, Jr.'s committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Gilbert Ray Cisneros, Jr. disclosed 1 other CRNX transaction (1 purchase) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded CRNX?
Quantellect's current database lists these recent CRNX disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| No recent disclosures by other members are available. | ||||
How has Gilbert Ray Cisneros, Jr.'s disclosed trading performed?
Gilbert Ray Cisneros, Jr. holds a Quantellect Q Score of 84 (strong), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.
Q Score rank #13 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.
All Gilbert Ray Cisneros, Jr. CRNX trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did Gilbert Ray Cisneros, Jr. buy or sell CRNX?
According to the disclosure, Gilbert Ray Cisneros, Jr. sold CRNX on July 30, 2026.
What amount was reported for the CRNX transaction?
The disclosure reports $15,001 - $50,000 for the sale. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated July 30, 2026, and it was disclosed on September 4, 2026.
Where can I see Gilbert Ray Cisneros, Jr.'s other congressional trades?
Quantellect lists Gilbert Ray Cisneros, Jr.'s complete disclosed trade history on the member profile. Gilbert Ray Cisneros, Jr.'s trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.